Ocugen, Inc. (NASDAQ: OCGN) Skyrockets 148% After Announcing Partnership to Co-Develop Covaxin, an Inactivated COVID-19 Vaccine Candidate
Ocugen, Inc. (NASDAQ: OCGN) is engaged as a biopharmaceutical company, which is primarily focused on the research, development, and commercialization ...